Document Detail


History. Development of new radiopharmaceuticals based on N-substitution of iminodiacetic acid. By Michael D. Loberg, Malcolm Cooper, Elizabeth Harvey, Patrick Callery, and William Faith. 1976.
MedLine Citation:
PMID:  6207277     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A new approach to radiopharmaceutical design is demonstrated, in which small chelating groups capable of binding gamma-emitting radiometals are attached to biologically active molecules, thus producing radiopharmaceuticals based on bifunctional drug and biochemical analogs. The chelating group iminodiacetic acid has been evaluated for this role by examining two N-substituted iminodiacetic acids: methyliminodiacetic acid (MIDA) and N-(2,6-dimethylphenylcarbamoylmethyl)iminodiacetic acid (HIDA). Radiochemical and biologic studies showed that both agents were obtained in high radiochemical purity, were stable in vitro and in vivo, and possessed biologic distributions governed almost exclusively by the N-substituted group. These characteristics of 99mTc-labled N-substituted iminodiacetic acids, prepared using an "instant kit" method, provide the basis for a valuable new class of radiopharmaceuticals based on bifunctional drug and biochemical analogs.
Authors:
-
Related Documents :
19456957 - Modèle mathématique pour l'étude des équilibres physico-chimiques de permanentes.
12535367 - Endoscopic endonasal approach to the pterygopalatine fossa: anatomic study.
18959957 - Acid-base indicator transition ranges in pyridine.
15724157 - Novel approach for mono-segmented flow micro-titration with sequential injection using ...
2977757 - Isolation and structure determination of the main related substances of teicoplanin, a ...
17618427 - Tolfenamic acid is a potent cyp1a2 inhibitor in vitro but does not interact in vivo: co...
Publication Detail:
Type:  Historical Article; Journal Article    
Journal Detail:
Title:  Journal of nuclear medicine : official publication, Society of Nuclear Medicine     Volume:  25     ISSN:  0161-5505     ISO Abbreviation:  J. Nucl. Med.     Publication Date:  1984 Oct 
Date Detail:
Created Date:  1984-11-14     Completed Date:  1984-11-14     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0217410     Medline TA:  J Nucl Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1144-9     Citation Subset:  IM; Q    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
History, 20th Century
Imino Acids / chemical synthesis*
Nuclear Medicine / history*
Sarcosine / analogs & derivatives
Technetium
Technetium Tc 99m Lidofenin
Chemical
Reg. No./Substance:
0/Imino Acids; 0/Technetium Tc 99m Lidofenin; 107-97-1/Sarcosine; 142-73-4/iminodiacetic acid; 4408-64-4/strombine; 7440-26-8/Technetium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characterization of L-glutamic acid transport by glioma cells in culture: evidence for sodium-indepe...
Next Document:  Infant leukemia and paternal exposure to motor vehicle exhaust fumes.